PT1438336E - Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos - Google Patents
Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentosInfo
- Publication number
- PT1438336E PT1438336E PT02774712T PT02774712T PT1438336E PT 1438336 E PT1438336 E PT 1438336E PT 02774712 T PT02774712 T PT 02774712T PT 02774712 T PT02774712 T PT 02774712T PT 1438336 E PT1438336 E PT 1438336E
- Authority
- PT
- Portugal
- Prior art keywords
- sialillacao
- medicines
- preparation
- high level
- fsh formulations
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33808801P | 2001-10-22 | 2001-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1438336E true PT1438336E (pt) | 2006-08-31 |
Family
ID=23323355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02774712T PT1438336E (pt) | 2001-10-22 | 2002-10-15 | Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20050085412A1 (pt) |
| EP (2) | EP1438336B1 (pt) |
| JP (1) | JP2005515974A (pt) |
| KR (1) | KR100929971B1 (pt) |
| CN (1) | CN1608078B (pt) |
| AR (1) | AR036926A1 (pt) |
| AT (1) | ATE329930T1 (pt) |
| AU (1) | AU2002340562B2 (pt) |
| CA (1) | CA2464368A1 (pt) |
| DE (1) | DE60212425T2 (pt) |
| DK (1) | DK1438336T3 (pt) |
| EA (1) | EA007030B1 (pt) |
| ES (1) | ES2261740T3 (pt) |
| HR (1) | HRP20040278B1 (pt) |
| IL (2) | IL161235A0 (pt) |
| ME (1) | MEP38608A (pt) |
| MX (1) | MXPA04003352A (pt) |
| NO (1) | NO327966B1 (pt) |
| PL (1) | PL369606A1 (pt) |
| PT (1) | PT1438336E (pt) |
| RS (1) | RS32804A (pt) |
| UA (1) | UA87433C2 (pt) |
| WO (1) | WO2003035686A2 (pt) |
| ZA (1) | ZA200402279B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0524782D0 (en) * | 2005-12-05 | 2006-01-11 | Chiron Srl | Analysis of samples |
| KR20170021375A (ko) | 2006-09-10 | 2017-02-27 | 글리코토페 게엠베하 | 항체 발현을 위한 골수성 백혈병 기원의 인간 세포의 용도 |
| CN101264096B (zh) * | 2007-03-12 | 2011-11-09 | 中国医学科学院药物研究所 | 人参皂苷Rg1在制备生精产品中的应用 |
| US8742079B2 (en) | 2007-08-20 | 2014-06-03 | Protalix Ltd. | Saccharide-containing protein conjugates and uses thereof |
| TWI488640B (zh) * | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| CA2795996A1 (en) * | 2009-04-22 | 2010-10-28 | The Regents Of The University Of California | In vivo 1h magnetic resonance spectroscopy for the diagnosis of testicular function and disease |
| TWI604850B (zh) | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| US9194011B2 (en) | 2009-11-17 | 2015-11-24 | Protalix Ltd. | Stabilized alpha-galactosidase and uses thereof |
| WO2012016576A1 (en) * | 2010-08-04 | 2012-02-09 | Glycotope Gmbh | Improved recombinant human follicle-stimulating hormone |
| CN102464713A (zh) * | 2010-12-21 | 2012-05-23 | 上海丽珠制药有限公司 | 一种卵泡刺激素的制备方法 |
| PL3272861T3 (pl) | 2011-01-20 | 2020-07-13 | Protalix Ltd. | Kompozycje alfa- galaktozydazy |
| US9757469B2 (en) | 2011-03-31 | 2017-09-12 | Ferring B.V. | Pharmaceutical preparation |
| WO2012168680A1 (en) * | 2011-06-06 | 2012-12-13 | Ferring B.V. | Pharmaceutical preparation comprising recombinant fsh |
| JO3092B1 (ar) * | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
| BR112016023668A2 (pt) | 2014-04-18 | 2017-10-17 | Glycotope Gmbh | hiperestimulação ovariana controlada com hormônio de estimulação de folículo humano recombinante aperfeiçoado |
| EP3794041B1 (en) | 2018-05-18 | 2023-07-12 | Glycotope GmbH | Anti-muc1 antibody |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1057895B (it) * | 1975-02-17 | 1982-03-30 | Serono Lab | Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione |
| IT1206302B (it) * | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| US5338835A (en) * | 1989-02-21 | 1994-08-16 | Washington University | CTP-extended form of FSH |
| US6225449B1 (en) * | 1991-10-04 | 2001-05-01 | Washington University | Hormone analogs with multiple CTP extensions |
| US5087615A (en) * | 1989-03-17 | 1992-02-11 | Applied Research Systems Ars Holding N.V. | Novel method of ovulation induction in humans |
| US5541083A (en) * | 1989-10-24 | 1996-07-30 | The Regents Of The University Of California | Method for producing secretable glycosyltransferases and other golgi processing enzymes |
| US5834251A (en) * | 1994-12-30 | 1998-11-10 | Alko Group Ltd. | Methods of modifying carbohydrate moieties |
| DE69823046T2 (de) * | 1997-01-16 | 2005-03-31 | Neose Technologies, Inc. | Praktische in vitro sialylierung von rekombinanten glykpproteinen |
| IL141063A (en) * | 1998-08-07 | 2005-06-19 | Applied Research Systems | Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility |
| AU1326200A (en) * | 1998-10-28 | 2000-05-15 | Baylor College Of Medicine | Ovary-specific genes and proteins |
| DK1171615T3 (da) * | 1999-04-26 | 2007-03-19 | Genentech Inc | Celledyrkningsfremgangsmåde for glycoproteiner |
| JP2001299362A (ja) * | 1999-12-17 | 2001-10-30 | Takeda Chem Ind Ltd | 新規ポリペプチドおよびそのｄｎａ |
| WO2001058493A1 (en) * | 2000-02-11 | 2001-08-16 | Maxygen Aps | Conjugates of follicle stimulating hormones |
-
2002
- 2002-10-15 ME MEP-386/08A patent/MEP38608A/xx unknown
- 2002-10-15 JP JP2003538199A patent/JP2005515974A/ja active Pending
- 2002-10-15 DK DK02774712T patent/DK1438336T3/da active
- 2002-10-15 IL IL16123502A patent/IL161235A0/xx unknown
- 2002-10-15 RS YUP-328/04A patent/RS32804A/sr unknown
- 2002-10-15 EA EA200400574A patent/EA007030B1/ru not_active IP Right Cessation
- 2002-10-15 AU AU2002340562A patent/AU2002340562B2/en not_active Ceased
- 2002-10-15 UA UA20040402998A patent/UA87433C2/ru unknown
- 2002-10-15 WO PCT/EP2002/011501 patent/WO2003035686A2/en active IP Right Grant
- 2002-10-15 PT PT02774712T patent/PT1438336E/pt unknown
- 2002-10-15 CA CA002464368A patent/CA2464368A1/en not_active Abandoned
- 2002-10-15 EP EP02774712A patent/EP1438336B1/en not_active Revoked
- 2002-10-15 DE DE60212425T patent/DE60212425T2/de not_active Revoked
- 2002-10-15 MX MXPA04003352A patent/MXPA04003352A/es active IP Right Grant
- 2002-10-15 US US10/493,638 patent/US20050085412A1/en not_active Abandoned
- 2002-10-15 AT AT02774712T patent/ATE329930T1/de not_active IP Right Cessation
- 2002-10-15 ES ES02774712T patent/ES2261740T3/es not_active Expired - Lifetime
- 2002-10-15 KR KR1020047005861A patent/KR100929971B1/ko not_active IP Right Cessation
- 2002-10-15 EP EP05107252A patent/EP1621549A3/en not_active Withdrawn
- 2002-10-15 PL PL02369606A patent/PL369606A1/xx not_active Application Discontinuation
- 2002-10-15 CN CN028260090A patent/CN1608078B/zh not_active Expired - Fee Related
- 2002-10-22 AR ARP020103989A patent/AR036926A1/es unknown
-
2004
- 2004-03-19 HR HR20040278A patent/HRP20040278B1/xx not_active IP Right Cessation
- 2004-03-23 ZA ZA2004/02279A patent/ZA200402279B/en unknown
- 2004-04-01 IL IL161235A patent/IL161235A/en unknown
- 2004-05-18 NO NO20042061A patent/NO327966B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60111769D1 (de) | Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit | |
| PT1438336E (pt) | Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos | |
| DE60107544D1 (de) | Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort | |
| DE60118008D1 (de) | Pharmazeutische zusammensetzungen mit amlodipinmaleat | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| PT1151008E (pt) | Peptidos artificiais com actividade de superficie e sua utilizacao na preparacao de tensioactivos artificiais | |
| ATE468324T1 (de) | Pharmazeutische zusammensetzung | |
| NO20010013L (no) | Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
| DE60213592D1 (de) | Flüssige pharmazeutische zusammensetzung | |
| ITTO20010008A0 (it) | Formulazione farmaceutica | |
| BR0112962B1 (pt) | Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos | |
| NO20032438D0 (no) | Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
| EE200200484A (et) | Väikeseannuseline entekaviiripreparaat ja selle kasutamine | |
| FI20000818A0 (fi) | Dermatologinen käyttö ja valmiste | |
| ATE324883T1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
| ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| PT1228039E (pt) | N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas | |
| IL159006A0 (en) | Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same | |
| PT1025100E (pt) | Derivados de tetra-hidropiridopirimidona substituidos na posicao 3 sua preparacao e sua utilizacao | |
| HRP20040171A2 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
| EP1203756A4 (en) | OPTICAL GLASS AND PROJECTION ALIGNER USING THE GLASS | |
| NO20014692L (no) | 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav | |
| AU2001251665A1 (en) | Medicine response assay in respiratory disease | |
| DE10291905D2 (de) | Pharmazeutische Zusammensetzung |